E. Khalifa

发表

Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms

F. Guyon, Gaëlle Pérot, I. Soubeyran, 2019, Modern Pathology.

Clinical impact of extensive molecular profiling in advanced cancer patients

I. Soubeyran, Y. Laizet, M. Toulmonde, 2017, Journal of Hematology & Oncology.

Homozygous deletion of an EGR2 enhancer in congenital amyelinating neuropathy

E. Hedley‐Whyte, L. Richard, J. Vallat, 2012, Annals of neurology.

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas

Aurélie Morin, Bertrand Dousset, Aurélien de Reyniès, 2015, Nature Communications.

Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma

A. Italiano, M. Brunet, E. Khalifa, 2019, Front. Oncol..

High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.

C. Lucchesi, I. Soubeyran, A. Italiano, 2017, European journal of cancer.

Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients

V. Brouste, I. Soubeyran, C. Primois, 2022, Journal of clinical pathology.

Targeting ERBB2 mutations in solid tumors: biological and clinical implications

C. Lucchesi, I. Soubeyran, Y. Laizet, 2018, Journal of Hematology & Oncology.

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial

J. Blay, P. Laurent-Puig, C. Lucchesi, 2021, BMC Cancer.

Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.

P. Rustin, A. Morin, R. Letón, 2014, Human molecular genetics.

Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy

C. Lucchesi, S. Mathoulin-Pélissier, I. Soubeyran, 2018, JAMA oncology.

Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations

Gaëlle Pérot, G. MacGrogan, I. Soubeyran, 2019, Modern Pathology.

A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL

A. Gimenez-Roqueplo, N. Burnichon, I. Bourdeau, 2016, The Journal of clinical endocrinology and metabolism.

Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan

P. Laurent-Puig, C. Lucchesi, S. Mathoulin-Pélissier, 2020, ESMO Open.

Genetic landscape of soft-tissue sarcomas: Moving toward personalized medicine.

C. Lucchesi, Y. Laizet, M. Toulmonde, 2017 .

An Algerian Family with TNF Receptor Associated Periodic Syndrome(TRAPS) Associated Amyloidosis and the p.Thr79Met Mutation

S. Amselem, M. Saidani, G. Grateau, 2018 .

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas

Y. Laizet, M. Toulmonde, A. Italiano, 2023, Cancer communications.

Are DNA Repair Gene Alterations Associated With the Response to Platinum-Based Regimen and Immune Checkpoint Inhibitors in Patients With Solid Tumors?

Y. Laizet, A. Crombé, E. Khalifa, 2024, The oncologist.

Pan‐TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls

I. Soubeyran, I. Hostein, F. Kommoss, 2023, Histopathology.